Emerging Infectious Diseases (Nov 2023)

Tuberculosis Variant with Rifampin Resistance Undetectable by Xpert MTB/RIF, Botswana

  • Chawangwa Modongo,
  • Ivan Barilar,
  • Qiao Wang,
  • Tuduetso Molefi,
  • Topo Makhondo,
  • Stefan Niemann,
  • Sanghyuk S. Shin

DOI
https://doi.org/10.3201/eid2911.230987
Journal volume & issue
Vol. 29, no. 11
pp. 2403 – 2406

Abstract

Read online

GeneXpert MTB/RIF, a tool widely used for diagnosing tuberculosis, has limitations for detecting rifampin resistance in certain variants. We report transmission of a pre–extensively drug-resistant variant in Botswana that went undetected by GeneXpert. The public health impact of misdiagnosis emphasizes the need for comprehensive molecular testing to identify resistance and guide treatment.

Keywords